Accuramed was founded in 2000 by Jozef Knez and quickly established itself as a leading Belgian distributor of cardiorespiratory medical devices, differentiating itself with an excellent service level and customer support, and a portfolio of leading products from partners such as Niox Group Plc and Geratherm Respiratory GmbH. Its growth was accelerated significantly by the entry of his sons Filip and Karel Knez, the current managers of the company, and geographical expansion to the Netherlands and Luxembourg.
In 2016, Accuramed established an additional segment by entering the laboratory market with a focus on molecular diagnostics and PCR testing, in a partnership with Seegene. Accuramed has quickly established a strong position in this market by offering an innovative solution that is highly automated, and enables the accurate detection of a wide range of organisms causing respiratory or gastrointestinal diseases or STD’s. More recently, this segment was expanded with a Point of Care offering to enable urgent testing in the doctor’s practice.
In the coming years, Accuramed wants to accelerate its growth trajectory, by further expanding its portfolio of innovative products and by entering new markets. In addition to organic growth, targeted acquisitions will also be part of the growth strategy.
“Highly innovative products and top-notch service levels have been the cornerstones of the growth we have realized over the past 24 years,” says Filip Knez, co-CEO of Accuramed. “In D2E we have found the ideal partner with an excellent track record in add-on acquisitions to accelerate our growth.”, he adds.
“We were immediately impressed by the strong product portfolio of Accuramed and the entrepreneurial drive of its management team,” says Ivo Marechal of Down2Earth. “Further leveraging its strong market position, we are convinced that Accuramed will be able to continue its rapid expansion, which we are happy to support.”